Cancer

Junshi Biosciences Announces New Chemical Entity Application for Toripalimab Accepted by Australia’s TGA

SHANGHAI, China, Dec. 01, 2023 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences,” HKEX: 1877; SSE: 688180), a…

1 year ago

Cosmos Health Announces Patent Filing for its Obesity and Weight Management Product

CHICAGO, IL / ACCESSWIRE / December 1, 2023 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified,…

1 year ago

Regeneron to Host Investor Call and Webcast on December 14, 2023 to Provide Updates Across Its Hematology Portfolio

TARRYTOWN, N.Y., Nov. 30, 2023 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will host a conference call and simultaneous…

1 year ago

Fred Says Announces Annual Giving on World AIDS Day

CHICAGO, IL / ACCESSWIRE / November 30, 2023 / On Dec. 1, World AIDS Day, Fred Says announced it is…

1 year ago

Jaguar Health to Present December 5 at the MedInvest Oncology Investor Conference

Top line data for Jaguar Health's pivotal phase 3 OnTarget trial of crofelemer for prophylaxis of diarrhea in adult cancer…

1 year ago

New Number of Shares and Votes in Cantargia

LUND, SE / ACCESSWIRE / November 30, 2023 / Cantargia (STO:CANTA)The number of shares and votes in Cantargia AB (publ)…

1 year ago

KKR, Hologic and Ajax Health Create New Platform to Accelerate Medical Device Innovation

Platform Will Focus on Technologies to Detect Lung Cancer, the Leading Cause of Cancer DeathsNEW YORK & MARLBOROUGH, Mass.--(BUSINESS WIRE)--KKR,…

1 year ago

Poolbeg Pharma PLC Announces Directorate Change

LONDON, UK / ACCESSWIRE / November 30, 2023 / Poolbeg Pharma (AIM:POLB)(OTCQB:POLBF, 'Poolbeg' or the 'Company'), a biopharmaceutical company focussed…

1 year ago

Theralase Release’s 3Q2023 Interim Financial Statements

TORONTO, ON / ACCESSWIRE / November 29, 2023 / Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage…

1 year ago

Theralase(R) Closes $CAN 1.17 Million Non-Brokered Private Placement

TORONTO, ON / ACCESSWIRE / November 29, 2023 / Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage…

1 year ago